| Detection of serum cross-reactive antibodies and memory response to SARS-CoV-2 in prepandemic and post–COVID-19 convalescent samples K Shrwani, R Sharma, M Krishnan, T Jones, M Mayora-Neto, D Cantoni, ... The Journal of infectious diseases 224 (8), 1305-1315, 2021 | 51 | 2021 |
| Isolation of infectious Lloviu virus from Schreiber’s bats in Hungary G Kemenesi, GE Tóth, M Mayora-Neto, S Scott, N Temperton, E Wright, ... nature communications 13 (1), 1706, 2022 | 38 | 2022 |
| Production, titration, neutralisation, storage and lyophilisation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lentiviral pseudotypes C Di Genova, A Sampson, S Scott, D Cantoni, M Mayora-Neto, E Bentley, ... Bio-protocol 11 (21), e4236-e4236, 2021 | 38 | 2021 |
| Analysis of serological biomarkers of SARS-CoV-2 infection in convalescent samples from severe, moderate and mild COVID-19 cases J Castillo-Olivares, DA Wells, M Ferrari, ACY Chan, P Smith, ... Frontiers in Immunology 12, 748291, 2021 | 27 | 2021 |
| The role of pseudotype neutralization assays in understanding SARS CoV-2 D Cantoni, M Mayora-Neto, N Temperton Oxford open immunology 2 (1), iqab005, 2021 | 26 | 2021 |
| Peste des petits ruminants virus infection at the wildlife–livestock interface in the greater Serengeti ecosystem, 2015–2019 BA Jones, M Mahapatra, D Mdetele, J Keyyu, F Gakuya, E Eblate, ... Viruses 13 (5), 838, 2021 | 25 | 2021 |
| Production, titration, neutralisation and storage of SARS-CoV-2 lentiviral pseudotypes C Di Genova, A Sampson, S Scott, D Cantoni, M Mayora-Neto, E Bentley, ... Bio-protocol 11 (21), 1-21, 2021 | 19 | 2021 |
| Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 disease J Castillo-Olivares, DA Wells, M Ferrari, A Chan, P Smith, ... medRxiv, 2021.05. 21.21257572, 2021 | 17 | 2021 |
| Coronavirus pseudotypes for all circulating human coronaviruses for quantification of cross-neutralizing antibody responses AT Sampson, J Heeney, D Cantoni, M Ferrari, MS Sans, C George, ... Viruses 13 (8), 1579, 2021 | 16 | 2021 |
| Neutralisation hierarchy of SARS-CoV-2 variants of concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards … D Cantoni, M Mayora-Neto, A Nadesalingam, DA Wells, GW Carnell, ... Frontiers in immunology 13, 773982, 2022 | 14 | 2022 |
| Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients KGI Mohn, G Bredholt, F Zhou, A Madsen, TB Onyango, EB Fjelltveit, ... PloS one 17 (2), e0261979, 2022 | 14 | 2022 |
| Different decay of antibody response and VOC sensitivity in naïve and previously infected subjects at 15 weeks following vaccination with BNT162b2 G Siracusano, A Ruggiero, Z Bisoffi, C Piubelli, LD Carbonare, MT Valenti, ... Journal of translational medicine 20 (1), 22, 2022 | 13 | 2022 |
| Production, titration, neutralisation and storage of SARS-CoV-2 lentiviral pseudotypes. figshare C Di Genova, A Sampson, S Scott, D Cantoni, M Mayora-Neto, E Bentley, ... Preprint. https://doi. org/10.6084/m9. figshare 13502580, v2, 2020 | 10 | 2020 |
| Correlation between pseudotyped virus and authentic virus neutralisation assays, a systematic review and meta-analysis of the literature D Cantoni, C Wilkie, EM Bentley, M Mayora-Neto, E Wright, S Scott, S Ray, ... Frontiers in Immunology 14, 1184362, 2023 | 9 | 2023 |
| Human seasonal coronavirus neutralization and COVID‐19 severity DA Wells, D Cantoni, M Mayora‐Neto, CD Genova, A Sampson, M Ferrari, ... Journal of Medical Virology 94 (10), 4820-4829, 2022 | 8 | 2022 |
| A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses S Vishwanath, GW Carnell, M Ferrari, B Asbach, M Billmeier, C George, ... Nature Biomedical Engineering, 1-14, 2023 | 7 | 2023 |
| Complement activation-independent attenuation of SARS-CoV-2 infection by C1q and C4b-binding protein N Beirag, PM Varghese, MM Neto, A Al Aiyan, HA Khan, M Qablan, ... Viruses 15 (6), 1269, 2023 | 7 | 2023 |
| Analysis of antibody neutralisation activity against SARS-CoV-2 variants and seasonal Human Coronaviruses NL63, HKU1, and 229E induced by three different COVID-19 vaccine platforms D Cantoni, G Siracusano, M Mayora-Neto, C Pastori, T Fantoni, S Lytras, ... Vaccines 11 (1), 58, 2022 | 7 | 2022 |
| Novel intranasal vaccine targeting SARS-CoV-2 receptor binding domain to mucosal microfold cells and adjuvanted with TLR3 agonist Riboxxim™ elicits strong antibody and T-cell … D Horvath, N Temperton, M Mayora-Neto, K Da Costa, D Cantoni, ... Scientific Reports 13 (1), 4648, 2023 | 6 | 2023 |
| Pseudotyped Bat Coronavirus RaTG13 is efficiently neutralised by convalescent sera from SARS-CoV-2 infected patients D Cantoni, M Mayora-Neto, N Thakur, AME Elrefaey, J Newman, ... Communications Biology 5 (1), 409, 2022 | 6 | 2022 |
